118 related articles for article (PubMed ID: 2151184)
1. The effect of prazosin therapy on platelet activation in essential hypertension.
Okrucká A; Pechán J; Mikulecký M
Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):813-9. PubMed ID: 2151184
[TBL] [Abstract][Full Text] [Related]
2. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
Okrucká A; Pechán J; Mikulecký M
Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
[TBL] [Abstract][Full Text] [Related]
3. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension.
Ikeda T; Nonaka Y; Goto A; Ishii M
Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807
[TBL] [Abstract][Full Text] [Related]
4. The effect of short-term celiprolol therapy on platelet function in essential hypertension.
Okrucká A; Pechán J; Balazovjech I
Cardiology; 1993; 82(6):399-404. PubMed ID: 8402762
[TBL] [Abstract][Full Text] [Related]
5. Different platelet aggregability during mental stress in two stages of essential hypertension.
Tomoda F; Takata M; Kagitani S; Kinuno H; Yasumoto K; Tomita S; Inoue H
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1063-70. PubMed ID: 10604481
[TBL] [Abstract][Full Text] [Related]
6. Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension.
Pechán J; Okrucká A
Cardiology; 1991; 79(2):116-9. PubMed ID: 1834333
[TBL] [Abstract][Full Text] [Related]
7. Platelet activity and salt sensitivity in the pathogenesis of systemic (essential) hypertension in black Africans.
Somova L; Mufunda J
Clin Exp Hypertens; 1993 Sep; 15(5):781-96. PubMed ID: 8401415
[TBL] [Abstract][Full Text] [Related]
8. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
9. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
Gerc V; Koblar V; Brkić D; Kamhi J
Med Pregl; 1992; 45(7-8):285-7. PubMed ID: 1344459
[TBL] [Abstract][Full Text] [Related]
10. Anti-hypertensive drugs non-specifically reduce "spontaneous" activation of blood platelets.
Wilson J; Orchard MA; Spencer AA; Davies JA; Prentice CR
Thromb Haemost; 1989 Sep; 62(2):776-80. PubMed ID: 2535678
[TBL] [Abstract][Full Text] [Related]
11. Effects of antihypertensive treatment on platelet function in essential hypertension.
Gomi T; Ikeda T; Shibuya Y; Nagao R
Hypertens Res; 2000 Nov; 23(6):567-72. PubMed ID: 11131267
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
[TBL] [Abstract][Full Text] [Related]
13. Platelet calcium and quenched-flow aggregation kinetics in essential hypertension.
Taylor MA; Ayers CR; Gear AR
Hypertension; 1989 Jun; 13(6 Pt 1):558-66. PubMed ID: 2525522
[TBL] [Abstract][Full Text] [Related]
14. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.
Larsson PT; Wallén NH; Martinsson A; Egberg N; Hjemdahl P
Thromb Haemost; 1992 Dec; 68(6):687-93. PubMed ID: 1337630
[TBL] [Abstract][Full Text] [Related]
15. Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.
Fetkovska N; Pletscher A; Ferracin F; Amstein R; Buhler FR
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():105-9. PubMed ID: 1704794
[TBL] [Abstract][Full Text] [Related]
16. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension.
Islim IF; Beevers DG; Bareford D
J Hypertens; 1992 Apr; 10(4):379-83. PubMed ID: 1349904
[TBL] [Abstract][Full Text] [Related]
17. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
18. The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study.
Hernandez Hernandez R; Carvajal AR; Guerrero Pajuelo J; Armas de Hernandez MJ; Armas Padilla MC; Barragan O; Boada Boada JJ; Roa E
Am Heart J; 1991 Jan; 121(1 Pt 2):389-94. PubMed ID: 1824665
[TBL] [Abstract][Full Text] [Related]
19. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
[TBL] [Abstract][Full Text] [Related]
20. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
